281 related articles for article (PubMed ID: 26983643)
1. Automation of cellular therapy product manufacturing: results of a split validation comparing CD34 selection of peripheral blood stem cell apheresis product with a semi-manual vs. an automatic procedure.
Hümmer C; Poppe C; Bunos M; Stock B; Wingenfeld E; Huppert V; Stuth J; Reck K; Essl M; Seifried E; Bonig H
J Transl Med; 2016 Mar; 14():76. PubMed ID: 26983643
[TBL] [Abstract][Full Text] [Related]
2. Automated CD34+ cell isolation of peripheral blood stem cell apheresis product.
Spohn G; Wiercinska E; Karpova D; Bunos M; Hümmer C; Wingenfeld E; Sorg N; Poppe C; Huppert V; Stuth J; Reck K; Essl M; Seifried E; Bönig H
Cytotherapy; 2015 Oct; 17(10):1465-71. PubMed ID: 25981397
[TBL] [Abstract][Full Text] [Related]
3. Automatic generation of alloreactivity-reduced donor lymphocytes and hematopoietic stem cells from the same mobilized apheresis product.
Wiercinska E; Quade-Lyssy P; Hümmer C; Beifuß J; Akarkach K; Poppe C; Olevska V; Dzionek J; Lahnor H; Bosio A; Papanikolaou E; Bonig H
J Transl Med; 2023 Nov; 21(1):849. PubMed ID: 38007485
[TBL] [Abstract][Full Text] [Related]
4. Preliminary evaluation of a highly automated instrument for the selection of CD34+ cells from mobilized peripheral blood stem cell concentrates.
Stroncek DF; Tran M; Frodigh SE; David-Ocampo V; Ren J; Larochelle A; Sheikh V; Sereti I; Miller JL; Longin K; Sabatino M
Transfusion; 2016 Feb; 56(2):511-7. PubMed ID: 26505619
[TBL] [Abstract][Full Text] [Related]
5. Generation of alloreactivity-reduced donor lymphocyte products retaining memory function by fully automatic depletion of CD45RA-positive cells.
Müller N; Landwehr K; Langeveld K; Stenzel J; Pouwels W; van der Hoorn MAWG; Seifried E; Bonig H
Cytotherapy; 2018 Apr; 20(4):532-542. PubMed ID: 29500069
[TBL] [Abstract][Full Text] [Related]
6. Isolation of purified autologous peripheral blood CD34+ cells with low T cell content using CliniMACS device--a local experience.
Leong CF; Habsah A; Teh HS; Goh KY; Fadilah SA; Cheong SK
Malays J Pathol; 2008 Jun; 30(1):31-6. PubMed ID: 19108409
[TBL] [Abstract][Full Text] [Related]
7. GMP-conformant on-site manufacturing of a CD133
Skorska A; Müller P; Gaebel R; Große J; Lemcke H; Lux CA; Bastian M; Hausburg F; Zarniko N; Bubritzki S; Ruch U; Tiedemann G; David R; Steinhoff G
Stem Cell Res Ther; 2017 Feb; 8(1):33. PubMed ID: 28187777
[TBL] [Abstract][Full Text] [Related]
8. Comparison of two different methods for CD34+ selection and T cell depletion in peripheral blood stem cell grafts--our experiences with CellPro, E rosetting and CliniMACS technique.
Poloucková A; Vodvárková A; Kobylka P; Hrubá A; Gasová Z; Marinov I; Fales I; Sedlácek P; Kozák T; Starý J
Neoplasma; 2001; 48(5):374-81. PubMed ID: 11845982
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of 'out-of-specification' CliniMACS CD34-selection procedures of hematopoietic progenitor cell-apheresis products.
Braakman E; Schuurhuis GJ; Preijers FW; Voermans C; Theunissen K; van Riet I; Fibbe WE; Slaper-Cortenbach I
Cytotherapy; 2008; 10(1):83-9. PubMed ID: 18202977
[TBL] [Abstract][Full Text] [Related]
10. Predictive value of the original content of CD34(+) cells for enrichment of hematopoietic progenitor cells from bone marrow harvests by the apheresis procedure.
Itoh T; Minegishi M; Kudo Y; Saito N; Takahashi H; Suzuki A; Narita A; Sato Y; Miura J; Inoue Y; Kameoka J; Suwabe N; Imaizumi M; Okuda M; Tsuchiya S
J Clin Apher; 2006 Oct; 21(3):176-80. PubMed ID: 16619225
[TBL] [Abstract][Full Text] [Related]
11. A CD34+ Cell Enrichment Protocol of Hematopoietic Stem Cells in a Well-Established Quality Management System.
Kilic P; Bay M; Yildirim Y; Coskun O; Seker S; Baydin P; Lalegul Ulker O; Parmaksiz M; Cubukcuoglu Deniz G; Yilmazer A; Dalva K; Elcin AE; Akcali KC; Ilhan O; Gurman G
Cells Tissues Organs; 2019; 207(1):15-20. PubMed ID: 31357194
[TBL] [Abstract][Full Text] [Related]
12. Comparative Analysis of Clinical-Scale IFN-γ-Positive T-Cell Enrichment Using Partially and Fully Integrated Platforms.
Priesner C; Esser R; Tischer S; Marburger M; Aleksandrova K; Maecker-Kolhoff B; Heuft HG; Goudeva L; Blasczyk R; Arseniev L; Köhl U; Eiz-Vesper B; Klöß S
Front Immunol; 2016; 7():393. PubMed ID: 27746781
[TBL] [Abstract][Full Text] [Related]
13. Depletion of T-cell receptor alpha/beta and CD19 positive cells from apheresis products with the CliniMACS device.
Schumm M; Lang P; Bethge W; Faul C; Feuchtinger T; Pfeiffer M; Vogel W; Huppert V; Handgretinger R
Cytotherapy; 2013 Oct; 15(10):1253-8. PubMed ID: 23993299
[TBL] [Abstract][Full Text] [Related]
14. G-CSF-mobilized peripheral blood progenitor cells for allogeneic transplantation: comparison of T cell depletion strategies using different CD34+ selection systems or CAMPATH-1.
Dreger P; Viehmann K; Steinmann J; Eckstein V; Müller-Ruchholtz W; Löffler H; Schmitz N
Exp Hematol; 1995 Feb; 23(2):147-54. PubMed ID: 7530212
[TBL] [Abstract][Full Text] [Related]
15. Use of laboratory tests to guide initiation of autologous hematopoietic progenitor cell collection by apheresis: results from the multicenter hematopoietic progenitor cell collection by Apheresis Laboratory Trigger Survey.
Makar RS; Padmanabhan A; Kim HC; Anderson C; Sugrue MW; Linenberger M
Transfus Med Rev; 2014 Oct; 28(4):198-204. PubMed ID: 25311468
[TBL] [Abstract][Full Text] [Related]
16. Monitoring blood for CD34+ cells to determine timing of Hematopoietic Progenitor Cells Apheresis.
Vaughn ML; Waller EK
Methods Mol Biol; 2012; 904():79-83. PubMed ID: 22890923
[TBL] [Abstract][Full Text] [Related]
17. Positive immunomagnetic CD34(+) cell selection in haplo-identical transplants in beta-thalassemia patients: removal of platelets using an automated system.
Zinno F; Landi F; Aureli V; Balduino G; Lanti A; Sodani P; Adorno G; Lucarelli G; Isacchi G
Cytotherapy; 2010; 12(1):60-6. PubMed ID: 19929454
[TBL] [Abstract][Full Text] [Related]
18. Semi-automated flow cytometric analysis of CD34-expressing hematopoietic cells in peripheral blood progenitor cell apheresis products.
Gutensohn K; Carrero I; Krueger W; Kroeger N; Schäfer P; Luedemann K; Kuehnl P
Transfusion; 1999; 39(11-12):1220-6. PubMed ID: 10604249
[TBL] [Abstract][Full Text] [Related]
19. Comparison between bone marrow and G-CSF-mobilized peripheral blood allografts undergoing clinical scale CD34+ cell selection.
Hassan HT; Zeller W; Stockschläder M; Krüger W; Hoffknecht MM; Zander AR
Stem Cells; 1996 Jul; 14(4):419-29. PubMed ID: 8843543
[TBL] [Abstract][Full Text] [Related]
20. Mobilization of peripheral blood stem cells following myelosuppressive chemotherapy: a randomized comparison of filgrastim, sargramostim, or sequential sargramostim and filgrastim.
Weaver CH; Schulman KA; Buckner CD
Bone Marrow Transplant; 2001 May; 27 Suppl 2():S23-9. PubMed ID: 11436117
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
